Imatinib Completed Phase N/A Trials for Hypereosinophilic Syndromes / Chronic Myelomonocytic Leukemia / Polycythemia Vera (PV) / Chronic Myeloid Leukemia (CML) / Urticaria Pigmentosa Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00038675Therapy of HES, PV, Atypical Chronic Myelocytic Leukemia (CML) or Chronic Myelomonocytic Leukemia (CMML), and Mastocytosis With Imatinib Mesylate